Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists

A novel quinuclidinyl heteroarylcarbamate derivative ASP9133 was identified as a long-acting muscarinic antagonist (LAMA) showing more selective inhibition of bronchoconstriction against salivation and more rapid onset of action than tiotropium bromide.